J. Lacava
Impact in
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
- Oncology top 5%
- Cancer Treatment and Pharmacology
- Colorectal Cancer Treatments and Studies
- HER2/EGFR in Cancer Research
Papers in
- Oncology 19
- Colorectal Cancer Treatments and Studies 10
- Cancer Treatment and Pharmacology 4
- Lung Cancer Research Studies 4
-
- Endometrial and Cervical Cancer Treatments 4
- Co-authors
- Carlos VallejoM. MachiavelliLeonard B. SaltzJennifer J. KnoxPhilip J. JohnsonMarinela CapanuGhassan K. Abou‐AlfaІрина Давиденко
- Journals
- Journal of Clinical Oncology (7 papers)British Journal of Cancer (2 papers)JAMA (1 paper)American Journal of Clinical Oncology (9 papers)Journal of Interferon & Cytokine Research (1 paper)
- Partner nations
- ArgentinaUnited StatesItaly
In The Last Decade
J. Lacava
30 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 64
- Hepatology 294
- Oncology 630
- Cancer Research 304
- Pathology and Forensic Medicine 324
- Obstetrics and Gynecology 98
Countries citing papers authored by J. Lacava
This map shows the geographic impact of J. Lacava's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Lacava with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Lacava more than expected).
Fields of papers citing papers by J. Lacava
This network shows the impact of papers produced by J. Lacava. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Lacava. The network helps show where J. Lacava may publish in the future.
Co-authorship network
The 25 scholars most cited alongside J. Lacava, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Doxorubicin Plus Sorafenib vs Doxorubicin Alone in Patients With Advanced Hepatocellular Carcinoma | 2013 | 12 |
| 2 | 2010 | 343 | |
| 3 | 2004 | 2 | |
| 4 | 2003 | 15 | |
| 5 | 2002 | 4 | |
| 6 | 2002 | 8 | |
| 7 | 2001 | 29 | |
| 8 | 2000 | 122 | |
| 9 | 1998 | 10 | |
| 10 | 1998 | 3 | |
| 11 | 1998 | 3 | |
| 12 | 1997 | 48 | |
| 13 | 1996 | 3 | |
| 14 | 1996 | 50 | |
| 15 | 1996 | 39 | |
| 16 | 1996 | 22 | |
| 17 | 1994 | 168 | |
| 18 | 1994 | 48 | |
| 19 | 1993 | 6 | |
| 20 | 1993 | 4 |
About J. Lacava
J. Lacava is a scholar working on Oncology, Obstetrics and Gynecology, Hepatology, Cancer Research and Pathology and Forensic Medicine, having authored 31 papers that have together received 1.2k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (10 papers), Colorectal and Anal Carcinomas (6 papers), Gastric Cancer Management and Outcomes (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Endometrial and Cervical Cancer Treatments (4 papers), Genetic factors in colorectal cancer (4 papers), Cancer Treatment and Pharmacology (4 papers) and Lung Cancer Research Studies (4 papers). The work is most often cited by research in Hepatology (294 citations), Oncology (630 citations), Cancer Research (304 citations), Pathology and Forensic Medicine (324 citations) and Obstetrics and Gynecology (98 citations). J. Lacava has collaborated with scholars based in Argentina, United States and Italy. Frequent co-authors include Carlos Vallejo, M. Machiavelli, Leonard B. Saltz, Jennifer J. Knox, Philip J. Johnson, Marinela Capanu, Ghassan K. Abou‐Alfa, Ірина Давиденко, Thomas W. T. Leung and B Leone. Their work appears in journals such as Journal of Clinical Oncology, British Journal of Cancer, JAMA, American Journal of Clinical Oncology and Journal of Interferon & Cytokine Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.